申请人:Insusense ApS
公开号:EP4079748A1
公开(公告)日:2022-10-26
The present invention relates to compounds of formula (I), which are modulators of sortilin activity. The invention also relates to pharmaceutical compositions comprising these compounds and to the use of these compounds in the treatment or prevention of medical conditions where modulation of sortilin activity is beneficial.
本发明涉及式(I)化合物,它们是索氏林活性的调节剂。 本发明还涉及包含这些化合物的药物组合物,以及这些化合物在治疗或预防有利于调节索司替林活性的病症中的用途。